Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Influenza, Human × Vaccines × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1 Multiple Myeloma 1 Influenza, Human 1

Interventions

trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine 2 thymoglobulin 1 peginterferon alfa-2a 1 fludarabine 1 Vaccines 1 Rituximab 1 Melphalan 1 Levetiracetam 1 Interferons 1 Interferon alpha-2 1 Influenza Vaccines 1 Cyclophosphamide 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02566265 2019-01-30

SHIVERING 2

Yale University

Phase 2 Completed

122 enrolled 10 charts

LymphoidPlasma cell

Influenza, Human, Waldenstrom Macroglobulinemia, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡